Question 1 - Gnosis Pay: Growth Has Stopped
The Dune dashboard shows weekly card volume peaked around $2.5M and has settled at roughly $2.1M. But the critical point isn’t the modest decline, it is that growth has completely flatlined for months. This plateau is happening during an active cashback programme funded by Gnosis Ltd through June 2026, meaning users are being paid to use the product and volume is still not growing. For a product positioned as the breakthrough use case justifying $30M/year in DAO funding, this is concerning.
What is Gnosis Ltd’s explanation for the growth stall, and what is the projected weekly volume if the cashback programme is not renewed after June 30th?
Question 2 - NAV Gap: Widening, Not Narrowing
GIP-146 passed Phase 2 with 87% support because GNO holders cannot assess the intrinsic value of what they own. Since then, the discount to NAV per circulating GNO has been widening, not narrowing. Despite GIP-143 and GIP-148 giving a clear mandate to put tokenholders first, there is still no published NAV, no mechanism for tokenholders to realize value, and the gap keeps growing.
Will Gnosis Ltd commit today to publishing a quarterly NAV per circulating GNO (of course excluding DAO-held and Ltd-held tokens) starting this quarter, and what concrete steps are being taken to narrow the discount rather than let it widen further?
Question 3 - The $30M Budget vs. Revenue Reality
Gnosis Ltd received its first quarterly tranche (~$7.5M) in Q3 2025, so we’re now roughly $22.5M into GIP-128’s mandate. Across all funded products (Pay, Chain, Business, App, Circles, VPN, AI) the community has seen transaction volume figures but no revenue disclosure.
What is the total actual revenue generated across all Gnosis Ltd products since GIP-128 funding began, and can you provide a per-product cost allocation for the $7.5M quarterly spend?
Question 4 - VC Portfolio: Two Years Without Disclosure
The DAO treasury holds significant off-chain venture and VC fund positions through GnosisVC and related entities. Full disclosure of these holdings has been requested for over two years. GIP-146 specifically mandated consolidated valuations for illiquid assets, yet nothing has been published.
Can you provide today - even at a summary level - the top 10 off-chain investments by cost basis with a current status (impaired, at cost, or marked up)? Can you also share the methodology and valuation basis for these illiquid investments?
Question 5 - Accountability for Renewal
GIP-128 was structured as a renewable annual mandate with quarterly reporting. We are three quarters in, yet there has been no quarterly report containing product-level P&L, cost allocation by business line, or measurable KPIs against which renewal should be judged.
What specific, measurable milestones does Gnosis Ltd commit to achieving before GIP-128 comes up for renewal, and will the team publish defined pass/fail renewal criteria agreed with the DAO before that vote?